With the help of 15 chapters spread over 100 pages this report describe Hidradenitis Suppurativa Treatment Introduction, product scope, market overview, market opportunities, market risk, and market driving force. Later it provide top manufacturers sales, revenue, and price of Hidradenitis Suppurativa Treatment, in 2017 and 2018 followed by regional and country wise analysis of sales, revenue and market share. Added to above, the important forecasting information by regions, type and application, with sales and revenue from 2018 to 2024 is provided in this research report. At last information about Hidradenitis Suppurativa Treatment sales channel, distributors, traders, dealers, and research findings completes the global Hidradenitis Suppurativa Treatment market research report.
Market share of global Hidradenitis Suppurativa Treatment industry is dominate by companies like GlaxoSmithKline, Johnson & Johnson, Merck, Pfizer, AbbVie, Allergan, AstraZeneca and others which are profiled in this report as well in terms of Sales, Price, Revenue, Gross Margin and Market Share (2018-2019).
Market Segment by Regions, regional analysis covers:
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers:
Medications
Surgery
Others
Market Segment by Applications, can be divided into
https://higenix.com/wp-content/uploads/2018/09/higenix-hs-treatment.png00Stevehttps://higenix.com/wp-content/uploads/2018/09/higenix-hs-treatment.pngSteve2019-12-31 20:43:152019-12-31 20:43:15Global Hidradenitis Suppurativa Treatment Market Deep Analysis: Sales and Revenue Market Share by Countries
Transparency Market Research, in its latest market intelligence study, finds that the global Hidradenitis Suppurativa market registered a value of ~US$ xx Mn/Bn in 2018 and is spectated to grow at CAGR of xx% during the foreseeable period 2019-2029. In terms of product type, segment holds the largest share, while segment 1 and segment 2 hold significant share in terms of end use.
The Hidradenitis Suppurativa market study outlines the key regions – Region 1 (Country 1, Country 2), region 2 (Country 1, Country 2), region 3 (Country 1, Country 2) and region 4 (Country 1, Country 2). All the consumption trends and adoption patterns of the Hidradenitis Suppurativa are covered in the report. Prominent players, including player 1, player 2, player 3 and player 4, among others, account for substantial shares in the global Hidradenitis Suppurativa market.
Limited discount offer!!! Purchase reports before the offer ends!!!
Latin America (Mexico, Brazil, Peru, Chile, and others)
Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
Eastern Europe (Poland and Russia)
Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
A complete backdrop analysis, which includes an assessment of the parent market
Important changes in market dynamics
Market segmentation up to the second or third level
Historical, current, and projected size of the market from the standpoint of both value and volume
Reporting and evaluation of recent industry developments
Market shares and strategies of key players
Emerging niche segments and regional markets
An objective assessment of the trajectory of the market
Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
The Hidradenitis Suppurativa market research answers important questions, including the following:
What was the number of units of the Hidradenitis Suppurativa sold in 2018?
Which distribution channel is best suitable for the distribution of Hidradenitis Suppurativa ?
How are the vendors overcoming the challenges associated with the use of Hidradenitis Suppurativa ?
What R&D projects are the Hidradenitis Suppurativa players implementing?
Which segment will lead the global Hidradenitis Suppurativa market by 2029 by product type?
The Hidradenitis Suppurativa market research serves a platter of the following information:
In-depth analysis of the drivers, restraints, opportunities and trends influencing the growth of the global Hidradenitis Suppurativa market.
Critical breakdown of the Hidradenitis Suppurativa market as per product type, and end use industry.
Exhaustive understanding of the strengths, weaknesses, opportunities and threats of various Hidradenitis Suppurativa market players.
Precise year-on-year growth of the global Hidradenitis Suppurativa market in terms of value and volume.
Regional analysis further broken down into countries for minute details.
Why go for Transparency Market Research?
Transparency Market Research stays aligned with the fact the organization lands among the leading market research firms in India. Our analysts work irrespective of the time-zone, the result, we are being recognized worldwide. We abide by the notion that each client has his/her own set of requirements. With extensive primary and secondary research, our experts churn out the most accurate information regarding the desired the market.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Contact
Transparency Market Research State Tower 90 State Street, Suite 700, Albany, NY – 12207 United States Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Email: [email protected] Website: http://www.transparencymarketresearch.co
A recently published review in Frontiers in Immunology highlights the efficacy of Janus kinase inhibitors as treatments for several dermatological ailments, including psoriasis. Authors described how newly researched pathologic factors have changed therapeutic practices used to treat inflammation and autoimmunity.
A recently published review in Frontiers in Immunology highlights the efficacy of Janus kinase (JAKs) inhibitors as treatments for several dermatological ailments, including psoriasis.
Authors described how newly researched pathologic factors have changed therapeutic practices used to treat inflammation and autoimmunity.
Interactions among cytokines, immune, and tissue cells are responsible for propagating inflammation in the skin, they explain. “Multiple cytokine receptors signal through JAKs and associated signal transducer and activators of transcription (STATs). Inhibition of JAKs can simultaneously block the function of multiple cytokines,” said the authors.
For this reason, JAK inhibitors are an emerging new class of drugs, capable of being administered both orally and topically. In the review, authors outline the immunological basis and current development stages of JAK inhibitors, pointing out their effective treatment of conditions such as atopic dermatitis and vitiligo.
“A variety of monoclonal antibodies (mAbs) targeting cytokines and small molecules interfering with intracellular signaling pathways have been developed,” the authors wrote. These recent breakthroughs can help combat diseases like alopecia areata, hidradenitis suppurativa, and psoriasis.
Specifically, “the implication of multiple cytokines…in psoriasis pathogenesis suggests that the inhibition of JAKs could be a powerful and more profound treatment than a treatment with a single mAb.” The authors also noted that JAKi tend to have lower production costs than mAbs, making them a more favorable option for dermatologists.
Studies have been conducted in both mice and humans with psoriasis. Both have yielded positive results due to the administration of JAK inhibitors. In addition, in the study conducted on humans only 6% of the patients treated reported adverse effects.
Based on the research, authors noted that oral administrations were superior to topical remedies. Multiple clinical trials are underway to test both forms.
“The expected results…will be a major step toward extending the therapeutic spectrum of psoriasis and psoriasis arthritis by oral compounds,” the authors said.
The anti-inflammatory properties of the treatment have been illustrated on multiple occasions, but authors urge caution due to the lack of long-term studies conducted on JAK inhibitors.
“We urgently need more evidence and larger double-blind placebo-controlled studies to confirm efficacy and safety of JAKi,” they said. Additionally, the simultaneous inhibition of multiple cytokines resulting from a systematic administration of JAK inhibitors “bears the risk for fatal outcomes during severe infections and possibly also the risk for cancer development on the long run.”
Reference
Solimani F, Meier K, Ghoreschi K. Emerging topical and systemic JAK inhibitors in dermatology. Front Immunol. 2019;10:2847. doi: 10.3389/fimmu.2019.02847.
Amy O’Connell, 34, from Beaconsfield, Buckinghamshire, has hidradenitis suppurativa – a painful long term condition that causes abscesses and scarring on the skin.
Speaking to Metro.co.uk for our You Don’t Look Sick series, Amy explains: ‘The sweat glands get blocked, which causes a cyst that is full of poison.
‘Sometimes it will rise to the surface and burst like a boil. This is excruciating.
‘More often than not they don’t rise to the surface, leaving a huge swelling under the skin that you can’t treat at all.
‘If this does heal, it leaves a pocket where it’s been and the next one will start there. It will grow around it and it causes huge clusters.
‘I began to get them in my groin at first, and then my armpits, then under my boobs and I get them randomly on my stomach and hips now.
‘The scars are not the end either. They leave uneven skin and deep wounds and some can take months and months to heal. Some never do heal completely.’
She has lived with the condition since her periods started as a teenager and her hormone levels started to change.
She explains: ‘They were always just diagnosed as boils. I was treated with so many different medicines but none of them worked.
Amy with her son Ralph (Picture: Maureen McLean for Metro.co.uk)
‘I was told it was because I was overweight so I lost weight. It didn’t stop.
‘I was told it was because of bacteria that was coming out my nose and settling in certain areas as the cysts would grow in the armpits, chest and groin.
‘I was told I wasn’t washing properly so I washed with an iodine solution for a while but they were still there.’
As she got older, the abscesses continued to appear but she wasn’t given any answers and nothing seemed to treat them.
She says: ‘It was always something I had done and nothing could help.
‘I was given seriously strong antibiotics but those would have me struggling due to side effects.
‘I just accepted this was something I had and this was the broken body I was given and I found a way to cope with it.’
Amy with her dogs Ernie and Derby (Picture: Maureen McLean for Metro.co.uk)
As she wasn’t given a diagnosis, the condition got much worse over time.
She explains: ‘I was making it worse and I had no idea. At the age of 15, I had a contraceptive injection which really upset my whole system and my hormone imbalances.
‘It was too much for my body and I think it definitely heightened the effects of the HS.’
Throughout her 20s, Amy struggled with the pain associated with HS as she almost constantly had boils on some part of her body.
It got much worse when she fell pregnant 13 years ago and had her daughter and again when she had her second child six years ago.
Eventually, her condition became so severe, she struggled to lift her arms.
She adds: ‘It was so bad for me. The cysts under my left arm were so big, which meant I couldn’t do things like lifting my children.
‘I developed little ways to do all sorts of things without lifting my arm fully. I don’t think anyone, even me, realised I was doing that.’
After her son was born, she happened to be watching daytime TV when she saw something that changed her life.
‘I was watching This Morning and a girl was on there saying her armpit had exploded,’ Amy said.
‘She was describing what happens when a huge cyst bursts.
Amy showing the scars under her arm (Picture: Amy O’Connell)
‘The girl in the story had one cyst but I had clusters on my whole body. I sat and sobbed. I had a name of something called hidradenitis suppurativa.
‘I went to see a doctor and said: “Do you think I have this?” They said yes but it was so bittersweet.’
Amy was told that although she now had a reason why this had been happening to her for so long, there was no cure for HS.
‘I thought now I was diagnosed I would get relief, but I realised I was just going to get new ways of dealing with it. It was never going away,’ she says.
‘I remember collapsing on the staircase in the hospital with my mum and my daughter and just sitting there sobbing.’
She started taking Roaccutane, which is a drug normally used for severe acne.
Although it helped with her symptoms, it caused other problems.
She adds: ‘It was the worst thing I ever took but it gave me the most relief I’ve ever had from this pain.
‘They basically dry you out from the inside. They were to try and stop me producing anything, anywhere. It dried my skin out. My mouth was always dry, my skin cracked and bled wherever you have to bend. My hair started to fall out. It was horrendous.’
But then Amy saw a new dermatologist who suggested that surgery could help to remove some of the disease from Amy’s body.
‘She looked at me and said “You know in Europe we just cut this out. Do you want surgery?”
‘I’d never known it was an option. I could have had it years ago. I could have never even gotten to this if I’d been diagnosed properly.
Amy’s arm after the surgery (Picture: Amy O’Connell)
‘As I left that appointment my whole world changed. I could feel myself and my life again and I could feel a way out.’
After that moment, Amy felt that her life was going to change. She left an abusive relationship after 10 years and decided to cut ties with her sister because they also had a difficult relationship.
She says that the condition had caused her self-confidence to diminish bit by bit but now she felt like she had a future.
She had the first operation in December 2014 to remove the disease in her left armpit, as this was the arm she couldn’t fully lift.
Amy says: ‘It totally changed my life. I went into the operation with the understanding that they didn’t really know how deep the swellings went or how much they would need to cut out until they got in there.
‘I went to sleep expecting skin grafts but I had extra skin on the back of my arm and I was given what is called a flap.
‘They cut the area out and used a piece of my own skin in its place. It was done with stitches and no skin grafts and the healing process was so different.
‘I was in tremendous pain when I woke up. I looked like a Frankenstein rag doll that had been sewn together in the dark.
‘It was hard on so many levels. My children couldn’t look at me as it was scary for them.
‘But instantly the pressure was gone and it was a million times better than before. I soldiered on and was doing school runs again within a few weeks.’
The sensation in her armpit has changed as some of the nerves have been damaged but she doesn’t have pain in that area like before.
In 2015, she had an operation on her chest to remove more of the disease but unfortunately, it was not as successful.
She says: ‘I don’t think there was much understanding of how bad it was. There was so much talk about my breasts and how they didn’t want to touch them but the disease was in there.
‘I even discussed having both breasts removed as a really extreme choice. It wasn’t necessary but I was prepared for everything to go to get this disease out.
‘I fell asleep thinking I would have skin grafts on my legs and buttocks and possibly a whole new chest, but I woke up almost the same.
‘They managed to cut it out up under until it hit my boob and then they stopped. I avoided skin grafts for a second time and they just pushed my stomach up a bit and glued and stitched.
‘Unfortunately, the disease grew back almost instantly along the scar and it can’t be operated on again. It didn’t work but it did take a good 60% of the pain.’
The operation severely impacted Amy’s mental health and she was angry that she had not had more removed before it grew back.
Skin was pulled up to cover the area that was removed (Picture: Amy O’Connell)
Following the setback, she wasn’t sure whether to continue with more surgery but in Summer 2017, she decided to have another operation on her right arm, again using staples and skin flaps.
Sadly, Amy was told that the disease is too widespread in her groin area and cannot be removed completely, which still causes her a huge amount of pain. They can operate on smaller areas that won’t heal but HS will always be there.
And although the operations she has had have helped, they have caused some other problems.
She explains: ‘I struggle to regulate my body temperature without sweat glands and have had blackouts in the summer.
‘I have had to carry iced bottles of water with me to cool me down as I walk and I have routes I know that are in the shade.
‘I also can’t wear a bra most days as the scars under my boobs are always sore and can be easily irritated and inflamed. I have big boobs and it isn’t easy but it’s worse to be in pain so I wear sports bras and tight clothes to keep everything in place.
Amy says she has learnt to be proud of her scars (Picture: Amy O’Connell)
‘I love to look good but need to always be in clothing that can breathe and doesn’t irritate. Jeans are a no-no.
‘I can’t use many lotions and products with perfumes and colours. Everything makes me sore and has the possibility of blocking my pores.’
Amy takes antibiotics and painkillers to try to control her symptoms – but those also affect her quality of life.
She says: ‘The antibiotics don’t take it away for long and I am developing immunity to some so they won’t work as well.
‘Painkillers, however, make me drowsy. I have had falls from being so drowsy.
‘I have a brilliant support network though. My daughter has dressed me in the past, helped me in and out of the bath and cared for me and her brother on a level that was unfair to her but we are a strong family unit.’
Amy also suffers from vitamin deficiencies because of the condition and it has had an impact on her whole body, as well as on her mental health.
Amy had surgery to manage some of the pain (Picture: Maureen McLean for Metro.co.uk)
She adds: ‘It can be hard and painful on my body and some days I can’t eat it hurts too much. Some days I can’t leave the house and I can’t face social situations anymore.
‘My hair is almost white/grey too from the stress and strain. I dye it purple and it gives me the strength to know I’m in control of my body choices wherever I can be.
‘It’s hard when a disease takes power from you but there are ways to take it back.
‘All of my friendships are on hold too. I’m not at a place where I can talk properly about this and so although I have friends, I struggle to have close relationships.’
Despite the difficulties of the condition, Amy says that she has started to come to terms with living with HS but says it is difficult for other people to understand.
She says: ‘I am so proud of these scars and I don’t want to be questioned about them.
‘I don’t really go out when I’m really bad but I have lied before when using disabled toilets. I have just said I need to use it because of a bad leg rather than saying its hidradenitis suppurativa.
‘I don’t want to have to educate someone or be on the receiving end of their ignorance or abuse or even their sympathy and pity.’
‘You don’t know what someone is going through so a bit of consideration for the people you see day-to-day is not much to ask for.’
How to get involved with You Don’t Look Sick
You Don’t Look Sick is Metro.co.uk’s weekly series that discusses invisible illness and disabilities.
https://i1.wp.com/higenix.com/wp-content/uploads/2019/12/PRI_111591897_1577610293.jpg?fit=1200%2C630&ssl=16301200Stevehttps://higenix.com/wp-content/uploads/2018/09/higenix-hs-treatment.pngSteve2019-12-29 12:39:262019-12-29 12:39:26You Don't Look Sick: Living with hidradenitis suppurativa
Hidradenitis Suppurativa (HS) is a painful, disfiguring chronic inflammatory disease that disproportionately affects underserved populations. Delayed diagnosis1 and lack of uniformly effective therapies2, 3 have contributed to HS patient suffering, despair, and reluctance to seek healthcare and participate in research. In recent years, over 60,000 patients have found support and health information through Facebook communities.
https://i0.wp.com/higenix.com/wp-content/uploads/2019/12/bjd.v181.6.cover.jpg?fit=754%2C1000&ssl=11000754Stevehttps://higenix.com/wp-content/uploads/2018/09/higenix-hs-treatment.pngSteve2019-12-29 04:21:322019-12-29 04:21:32Identifying Barriers to Care and Research in Hidradenitis Suppurativa: Findings from a Patient Engagement Event - Shukla - - British Journal of Dermatology
https://higenix.com/wp-content/uploads/2018/09/higenix-hs-treatment.png00Stevehttps://higenix.com/wp-content/uploads/2018/09/higenix-hs-treatment.pngSteve2019-12-27 21:08:392019-12-27 21:08:39Healio highlights top dermatology news of the year, decade
The global Hidradenitis Suppurativa Treatment market report offers fine intelligence that prepares market players to compete well against their toughest competitors on the basis of growth, sales, and other vital factors. The research study lays emphasis on key growth opportunities and market trends apart from critical market dynamics including market drivers and challenges. With the help of this report, interested parties can equip themselves to adapt according to the changes in the Hidradenitis Suppurativa Treatment industry and secure a strong market position for years to come. The report provides market development statistics, a list of select leading players, deep regional analysis, and a broad market segmentation study to give a complete understanding of the global Hidradenitis Suppurativa Treatment market.
The report is compiled using advanced primary and secondary research techniques and sophisticated market analysis tools. Our analysts conduct personal as well as telephonic interviews to collect information related to the Hidradenitis Suppurativa Treatment industry. They also refer company websites, government documents, press releases, annual and financial reports, and databases of organizations in authoritative positions in the Hidradenitis Suppurativa Treatment industry. We do not include any data or information in the report unless it is cross-verified with reliable entities.
This report focuses on the global top players, covered GlaxoSmithKline Johnson & Johnson Merck Pfizer AbbVie Allergan AstraZeneca …
Market segment by Regions/Countries, this report covers North America Europe China Rest of Asia Pacific Central & South America Middle East & Africa
Market segment by Type, the product can be split into Medications Surgery Others
Market segment by Application, the market can be split into Hospitals Clinics Others
What will the report include?
Market Dynamics: The report shares important information on influence factors, market drivers, challenges, opportunities, and market trends as part of market dynamics.
Global Market Forecast: Readers are provided with production and revenue forecasts for the global Hidradenitis Suppurativa Treatment market, production and consumption forecasts for regional markets, production, revenue, and price forecasts for the global Hidradenitis Suppurativa Treatment market by type, and consumption forecast for the global Hidradenitis Suppurativa Treatment market by application.
Regional Market Analysis: It could be divided into two different sections: one for regional production analysis and the other for regional consumption analysis. Here, the analysts share gross margin, price, revenue, production, CAGR, and other factors that indicate the growth of all regional markets studied in the report.
Market Competition: In this section, the report provides information on competitive situation and trends including merger and acquisition and expansion, market shares of top three or five players, and market concentration rate. Readers could also be provided with production, revenue, and average price shares by manufacturers.
How can the research study help your business?
(1) The information presented in the report helps your decision makers to become prudent and make the best business choices.
(2) The report enables you to see the future of the global Hidradenitis Suppurativa Treatment market and accordingly take decisions that will be in the best interest of your business.
(3) It offers you a forward-looking perspective of the global Hidradenitis Suppurativa Treatment market drivers and how you can secure significant market gains in the near future.
(4) It provides SWOT analysis of the global Hidradenitis Suppurativa Treatment market along with useful graphics and detailed statistics providing quick information about the market’s overall progress throughout the forecast period.
(5) It also assesses the changing competitive dynamics of the global Hidradenitis Suppurativa Treatment market using pin-point evaluation.
The report answers several questions about the Hidradenitis Suppurativa Treatment market includes:
What will be the market size of Hidradenitis Suppurativa Treatment market in 2025? What will be the Hidradenitis Suppurativa Treatment growth rate in 2025? Which key factors drive the market? Who are the key market players for Hidradenitis Suppurativa Treatment? Which strategies are used by top players in the market? What are the key market trends in Hidradenitis Suppurativa Treatment? Which trends and challenges will influence the growth of market? Which barriers do the Hidradenitis Suppurativa Treatment markets face? What are the market opportunities for vendors and what are the threats faced by them? What are the most important outcomes of the five forces analysis of the Hidradenitis Suppurativa Treatment market?
https://i2.wp.com/higenix.com/wp-content/uploads/2019/12/Add-a-heading-1.jpg?fit=650%2C366&ssl=1366650Stevehttps://higenix.com/wp-content/uploads/2018/09/higenix-hs-treatment.pngSteve2019-12-27 12:49:372019-12-27 12:49:37Hidradenitis Suppurativa Treatment Market Shows Outlook and Analysis by Manufacturers with Regions also includes Type and Application, Forecast and Industrial Analysis to 2025
https://higenix.com/wp-content/uploads/2018/09/higenix-hs-treatment.png00Stevehttps://higenix.com/wp-content/uploads/2018/09/higenix-hs-treatment.pngSteve2019-12-23 17:23:262019-12-23 17:23:26Access to this page has been denied.
Although the role of immune dysregulation in hidradenitis suppurativa (HS) has yet to be elucidated, recent studies identified several complement abnormalities in patients with HS. The complement system serves a critical role in the modulation of immune response and regulation of cutaneous commensal bacteria. Complement is implicated in several inflammatory skin diseases including systemic lupus erythematosus, angioedema, pemphigus, bullous pemphigoid, and HS. A model of HS pathogenesis is proposed, integrating the role of commensal bacteria, cutaneous immune responses, and complement dysregulation. The role of complement in disease pathogenesis has led to the development of novel anticomplement agents and clinical trials investigating the efficacy of such treatments in HS.
https://i2.wp.com/higenix.com/wp-content/uploads/2019/12/elsevier-non-solus.png?fit=145%2C160&ssl=1160145Stevehttps://higenix.com/wp-content/uploads/2018/09/higenix-hs-treatment.pngSteve2019-12-22 03:00:372019-12-22 03:00:37Role of the Complement Pathway in Inflammatory Skin Diseases: A Focus on Hidradenitis Suppurativa
InStyle‘s State of Skin study found that a whopping 76% of the women we surveyed said they felt good about themselves if they thought their skin looked good, regardless of age. While their specific concerns varied, depending on how old or young they were, there’s no question that the overall appearance of their skin played a vital role when it came to their confidence — and both mental health professionals and dermatologists agree.
“A bad skin day can have a tremendous impact on a woman’s self-esteem,” Miami-based dermatologist Dr. Heather Woolery-Lloyd shares. “In some cases, patients have told me that an especially severe breakout can even stop them from going to school or work.”
Zakiyyah Abdul-Mateen has heard similar stories from her patients in her psychotherapy practice — and she knows exactly why so many feel this way. “As humans, we are conditioned to look at outward expressions of the people we meet — our skin is commonly identified as the outward expression of beauty,” she explains. “From childhood to adulthood, we gather beliefs about ourselves based on others’ opinions. These beliefs then shape how we feel about ourselves and how we behave.”
The mental health professional also adds that even though most are aware that it’s completely normal and natural for the skin to fluctuate from time-to-time, the appearance of blemished skin is still seen as something that many believe needs to be covered up in order to be acceptable. “Being confident in oneself despite having acne or any other skin condition takes time and patience,” she says, as a result of society’s beliefs on skin and beauty.
The idea that certain types of skin needs to be hidden can be detrimental for some, as they’re often left feeling isolated — even when they experience common skin ailments like melasma, a condition that causes patches of the skin to become dark or discolored, as well as acne. “I always explain that they are not alone,” Dr. Woolery-Lloyd shares.
“For women, melasma can be devastating,” she continues. “Without treatment, it is hard to cover with makeup. It is typically right in the center of the cheeks or forehead so it is the first thing people see. Similar to melasma, adult working women feel embarrassed to have a face full of acne. It makes them feel less professional, especially for people with jobs where they are presenting or meeting many new people daily.”
VIDEO: 5 Celeb-Approved Skincare Products Under $50
That’s where the importance of skincare comes in, which the MD describes as “life-changing” for many. Not only in the sense that these products can help to treat the physical condition, but also because it helps to form self-care routines — both of which work together to improve mental health.
“It’s a form of self-love, self-acceptance, and healing,” Abdul-Mateen says. “There are certain points on the body that promotes relaxation, and the face is one of them. Using skin-to-skin contact, fingers to face, allows the blood to flow while also allowing the muscles in the face to relax. This alone sends a signal to the brain that you are in a state of relaxation putting you in a peaceful mindset.” And that’s regardless of the outcome of the products.
A 2010 study published in the Asian Journal of Beauty & Cosmetologyfurther justifies the psychotherapist’s point from a global standpoint. The research found that among middle age and eldery women across Korea, having a dedicated skincare routine helps them to have a boost in confidence, thus leading to improvements in self-efficacy, self-esteem, and overall happiness.
Scientists are taking note of the impact skincare has on improving mental health as well. “Now, the FDA is asking pharmaceutical companies to include improvement in the quality of life (QoL) scores in dermatology clinical trials,” Dr. Woolery-Lloyd shares. “In some ways, improvement in the quality of life is just as important as the measured improvement in the disease.”
If you’ve noticed that your skin is having a negative effect on your mental health, the MD advises that the first step to healing is realizing that your feelings are valid, and shared with many others — being upset that your skin does not look how you want it to is not an “overreaction,” she says. It’s also important to remember that regardless of what your skincare journey looks like, taking the time to take care of yourself can do wonders for improving your mental health.
Secondly, seeing a board-certified dermatologist you trust is vital when it comes to figuring out an effective treatment plan to guide you to reach your skincare goals, which in turn will help to clear your mind. It’s also a good idea to seek the help of a mental health professional who can work with you to deal with the emotional aspects of living with a skin condition, because while it may seem isolating, it’s important to know that there are people who can help.
https://higenix.com/wp-content/uploads/2019/12/5e30a58332166be3e096cd05b43824e540006000Stevehttps://higenix.com/wp-content/uploads/2018/09/higenix-hs-treatment.pngSteve2019-12-21 16:31:442019-12-21 16:31:44How Your Skin and Skincare Routine Can Impact Your Mental Health